https://www.fresenius.com en-us Tue, 27 May 2025 17:00:00 +0200 Tue, 27 May 2025 17:00:00 +0200 Tue, 27 May 2025 17:00:00 +0200 Tue, 27 May 2025 15:35:00 +0200 Fri, 23 May 2025 23:50:00 +0200 Fri, 23 May 2025 16:00:00 +0200 Annual General Meeting | FSE About Fresenius Fresenius SE & Co. KGaA (Frankfurt/Xetra: FRE) is a global healthcare company headquartered n Bad Homburg v. d. Höhe, Germany. In the 2024 fiscal year, Fresenius generated €21.5 billion in annual revenue. Fresenius currently counts over 176,000 employees. The Fresenius Group comprises the operating companies Fresenius Kabi and Fresenius Helios as well as an investment in Fresenius Medical Care. With around 140 hospitals and countless outpatient facilities, Fresenius Helios is the leading private hospital operator in Germany and Spain, treating around 26 million patients every year. Fresenius Kabi’s product portfolio touches the lives of 450 million patients annually and includes a range of highly complex biopharmaceuticals, clinical nutrition, medical technology, and intravenous generic drugs and fluids. Fresenius was established in 1912 by the Frankfurt pharmacist Dr. Eduard Fresenius. After his death, Else Kröner took over management of the company in 1952. She laid the foundations for a global enterprise that today pursues the goal of improving people’s health. The largest shareholder is the non-profit Else Kröner-Fresenius Foundation, which is dedicated to advancing medical research and supporting humanitarian projects. For more information visit the Company’s website at www.fresenius.com Follow us on social media: www.fresenius.com/socialmedia]]> Tue, 20 May 2025 21:00:00 +0200 Sun, 18 May 2025 03:00:00 +0200 Wed, 07 May 2025 12:47:00 +0200 Thu, 10 Apr 2025 01:00:00 +0200 Tue, 01 Apr 2025 17:00:00 +0200 Wed, 26 Mar 2025 23:00:00 +0100 here. Please click to see full  Prescribing Information for Conexxence®. Please click to see full  Prescribing Information  for Bomyntra®.  ]]> Wed, 26 Mar 2025 21:00:00 +0100 European Sustainability Reporting Standards (ESRS). This replaces the Non-financial Report of previous Annual Reports and expands and supplements reporting topics and details. In addition, the ESRS report, like the financial report, is audited externally.   The 2024 Annual Report is available in German and English as a PDF file and as an online version.   Further publication and event dates for 2025:   ·       04/24/2025: Publication of Sustainability Highlights Magazine ·       05/07/2025: Publication of the financial results for Q1 2025 ·       05/23/2025: Annual General Meeting ·       08/06/2025: Publication of the financial results for Q2 2025 ·       11/05/2025: Publication of the financial results for Q3 2025  ]]> Mon, 17 Mar 2025 17:00:43 +0100 Tue, 04 Mar 2025 15:00:00 +0100 Tue, 04 Mar 2025 00:45:59 +0100 Mon, 03 Mar 2025 21:00:00 +0100 Wed, 26 Feb 2025 13:45:00 +0100 Mon, 03 Feb 2025 15:00:00 +0100 Tue, 28 Jan 2025 22:00:00 +0100 Thu, 23 Jan 2025 16:08:30 +0100 Fri, 20 Dec 2024 18:00:00 +0100